Dall’antibiotico Zimox al farmaco per gli stadi iniziali del Parkinson, l’elenco aggiornato dall’Aifa dei medicinali “scomparsI” dalle farmacie italiane
9 GIUGNO 2016 – Bussola Sanità
Some medicines I am unavailable in Italian pharmacies. Parkinson's, severe respiratory diseases, epilepsy, infections, rheumatoid arthritis, headaches, high cholesterol, pains of various kinds: there are so many problems that risk remaining unanswered or forcing patients to change treatment.
Difficult to quantify the people involved: according to data from the Italian Medicines Agency (Aifa), they are two million Italians who find out every year that their drug is not available. The phenomenon, which has become more pronounced in recent months, has now forced AIFA to draw up acomplete and updated list of missing drugs in our country.
THE LIST OF MISSING DRUGS
Even the Valium, a tranquilizer for the treatment of anxiety states, has become practically unobtainable. as well as theHypnovel, the hypnotic drug used by anesthesiologists for sedation before surgery, and the Requip, belonging to the class of dopamine agonists effective in Parkinson's treatment therapyin the early stages of the disease.
Among the untraceable medicines, also the vaccine for children which protects, among other things, from diphtheria, tetanus, whooping cough and polio. Aifa has drawn up a complete list of missing drugs.
WHAT TO DO IF THE DRUG IS MISSING
To help limit the discomfort of the lack of medicines, the AIFA managers recommend making one reporting to the regional Pharmaceutical Services. “Abbiamo messo a punto l’elenco delle carenze, aggiornato ogni due settimane – ha dichiarato Domenico di Giorgio, direttore dell’Ufficio qualità dei prodotti dell’Aifa – per dare riscontri tempestivi ai cittadini, segnalare la natura del problema e i tempi previsti per una eventuale soluzione”
BECAUSE SOME DRUGS ARE LACKING IN ITALY
The causes of the unavailability of some medicines in our country concern various fields. Some medicines are not found for production problems which may be related to awrong calculation of supplies for our country or a general slowdown at the industrial site.
But the "disappearance" of some drugs, reports AIFA, is also the fault of distribution difficulties, of corporate choices that prefer the sale of certain types of medicines because they are more profitable economically speaking, to the detriment of others.
Related news: The National Association of Pharmacists Wholesalers is born, a new interlocutor within the pharmaceutical supply chain